(Press-News.org) CHICAGO --- For hundreds of thousands of people, injuring a muscle through an accident like falling off a bike or having surgery can result in a strange and serious complication. Their muscles start growing bones.
No one understood what caused the abnormal bone growth, so there was no treatment. But now, research from Northwestern University Feinberg School of Medicine and the Perelman School of Medicine at the University of Pennsylvania shows that a neuropeptide in the brain called Substance P appears to trigger the formation of the extraskeletal bone. Eliminating Substance P prevents the bone growth.
The discovery -– in human and animal tissues -- offers a molecular target for drugs to potentially prevent and treat the abnormal bone growth, which is called heterotopic ossification.
"Patients who have it become very uncomfortable, and there is no way to make it go away," said Jack Kessler, M.D., chair of neurology at Northwestern's Feinberg School, a neurologist at Northwestern Memorial Hospital and the senior author of the paper, which was published in the Journal of Cellular Biochemistry. "This explains why it happens and gives us a way to develop a therapy to potentially treat it."
Lixin Kan, research associate professor at Feinberg and lead author of the paper, found that Substance P is dramatically increased in newly damaged tissue of patients who have the more common heterotopic ossification as well as a rarer and debilitating genetic disease. In the genetic disease, connective tissue begins to ossify and turn into bone. It's called fibrodysplasia ossificans progressiva (FOP).
In the paper, Kan reports that knocking out Substance P in animals prevented the development of the extraskeletal bone in an animal model.
"This work establishes a common mechanism underlying lesion induction for nearly all forms of heterotopic ossification including brain and spinal cord injury, peripheral nerve injury, athletic injury, total hip replacement and FOP," said paper co-author Frederick Kaplan, the Isaac & Rose Nassau Professor of Orthopaedic Molecular Medicine at Penn's Perelman School. "These novel findings usher in a new era in understanding of these complex disorders."
### END
When injured muscles mistakenly grow bones
Researchers discover brain chemical that causes strange, serious complication
2011-07-22
ELSE PRESS RELEASES FROM THIS DATE:
Work engagement, job satisfaction, and productivity -- they're a virtuous cycle
2011-07-22
Engaged workers—those who approach their work with energy, dedication, and focus—are more open to new information, more productive, and more willing to go the extra mile. Moreover, engaged workers take the initiative to change their work environments in order to stay engaged.
What do we know about the inner workings of work engagement, and how can employers enhance it to improve job performance? In a new article to be published in the August issue of Current Directions in Psychological Science , a journal of the Association for Psychological Science, Arnold B. Bakker ...
Caltech researchers create the first artificial neural network out of DNA
2011-07-22
PASADENA, Calif.—Artificial intelligence has been the inspiration for countless books and movies, as well as the aspiration of countless scientists and engineers. Researchers at the California Institute of Technology (Caltech) have now taken a major step toward creating artificial intelligence—not in a robot or a silicon chip, but in a test tube. The researchers are the first to have made an artificial neural network out of DNA, creating a circuit of interacting molecules that can recall memories based on incomplete patterns, just as a brain can.
"The brain is incredible," ...
As new data wave begins, a gene study in one disease discovers mutations in an unrelated disease
2011-07-22
Often enough, in science as in life, unexpected knowledge has a personal impact. Researchers seeking rare gene variants in just a few individuals with attention-deficit hyperactivity disorder (ADHD) discovered that one patient had a novel combination of two mutations. Those mutations caused a different disease, unrelated to ADHD—a blood disorder called idiopathic hemolytic anemia.
Although the man had long contended with the blood disease, "idiopathic" meant that physicians were unable to determine the cause of his particular anemia—until now, say authors of a new study.
As ...
Animal model sheds light on rare genetic disorder, signaling pathway
2011-07-22
SALT LAKE CITY – A team of researchers from the University of Utah and Brigham Young University has developed a mouse model of focal dermal hypoplasia, a rare human birth defect that causes serious skin abnormalities and other medical problems. This animal model not only provides insight into studying the cause of focal dermal hypoplasia (FDH), but also offers a novel way to study a signaling pathway that is crucial for embryonic development.
The findings were published July 19, 2011, online in the Proceedings of the National Academy of Sciences.
FDH is an uncommon ...
Genetic map of African-Americans to aid study of diseases, human evolution
2011-07-22
JACKSON, Miss. – A group of researchers from the University of Oxford, Harvard Medical School and the University of Mississippi Medical Center has constructed the world's most detailed genetic map, a tool scientists can use to better understand the roots of disease and how DNA is passed generationally to create diversity in the human species.
About 5,000 Jackson-area volunteers were included in a group of nearly 30,000 African-Americans whose genetic information the scientists used to create the map.
The map pinpoints genome locations where people splice together DNA ...
URMC researchers exploring keys to melanoma progression
2011-07-22
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the most modern therapies, known as VEGF inhibitors. University of Rochester researchers, however, made an important discovery about proteins that underlie and stimulate the disease, opening the door for a more targeted treatment in the future.
This month in the journal Cancer Research, Lei Xu, Ph.D., assistant professor of Biomedical Genetics at the University of Rochester Medical ...
TGen, Virginia G. Piper Cancer Center studying new breast cancer drug
2011-07-22
SCOTTSDALE, Ariz. — July 20, 2011 — A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology (ASCO).
The drug under investigation, GDC-0941, manufactured by Genentech Inc., South San Francisco, Calif., targets the PI3K gene, which is abnormal in about 20-30 percent of patients with advanced ...
Fast prediction of axon behavior
2011-07-22
Researchers at Case Western Reserve University have developed a computer modeling method to accurately predict how a peripheral nerve axon responds to electrical stimuli, slashing the complex work from an inhibitory weeks-long process to just a few seconds.
The method, which enables efficient evaluation of a nerve's response to millions of electrode designs, is an integral step toward building more accurate and capable electrodes to stimulate nerves and thereby enable people with paralysis or amputated limbs better control of movement.
To increase the accuracy of the ...
U of M researchers discover gene required to maintain male sex throughout life
2011-07-22
MINNEAPOLIS / ST. PAUL (July 20, 2011) – University of Minnesota Medical School and College of Biological Sciences researchers have made a key discovery showing that male sex must be maintained throughout life.
The research team, led by Drs. David Zarkower and Vivian Bardwell of the U of M Department of Genetics, Cell Biology and Development, found that removing an important male development gene, called Dmrt1, causes male cells in mouse testis to become female cells.
The findings are published online today in Nature.
In mammals, sex chromosomes (XX in female, XY ...
Research outlines math framework that could help convert 'junk' energy into useful power
2011-07-22
BUFFALO, N.Y. -- A University at Buffalo-led research team has developed a mathematical framework that could one day form the basis of technologies that turn road vibrations, airport runway noise and other "junk" energy into useful power.
The concept all begins with a granular system comprising a chain of equal-sized particles -- spheres, for instance -- that touch one another.
In a paper in Physical Review E this June, UB theoretical physicist Surajit Sen and colleagues describe how altering the shape of grain-to-grain contact areas between the particles dramatically ...
LAST 30 PRESS RELEASES:
New deep-learning tool can tell if your salmon is wild or farmed
If you're over 60 and playing with sex toys, you're not alone
Fame itself may be critical factor in shortening singers’ lives
Daily coffee drinking may slow biological ageing of people with major mental illness
New highly efficient material turns motion into power – without toxic lead
The DEVILS in the details: New research reveals how the cosmic landscape impacts the galaxy lifecycle
After nearly 100 years, scientists may have detected dark matter
Gender imbalance hinders equitable environmental governance, say UN scientists
Six University of Tennessee faculty among world’s most highly cited researchers
A type of immune cell could hold a key to preventing scar tissue buildup in wounds
Mountains as water towers: New research highlights warming differences between high and low elevations
University of Tennessee secures $1 million NSF grant to build semiconductor workforce pipeline
Biochar shows powerful potential to build cleaner and more sustainable cities worldwide
UT Health San Antonio leads $4 million study on glucagon hormone’s role in diabetes, obesity
65-year-old framework challenged by modern research
AI tool helps visually impaired users ‘feel’ where objects are in real time
Collaborating minds think alike, processing information in similar ways in a shared task
Routine first trimester ultrasounds lead to earlier detection of fetal anomalies
Royal recognition for university’s dementia work
It’s a bird, it’s a drone, it’s both: AI tech monitors turkey behavior
Bormioli Luigi renews LionGlass deal with Penn State after successful trial run
Are developers prepared to control super-intelligent AI?
A step toward practical photonic quantum neural networks
Study identifies target for disease hyper progression after immunotherapy in kidney cancer
Concordia researchers identify key marker linking coronary artery disease to cognitive decline
HER2-targeted therapy shows promising results in rare bile duct cancers
Metabolic roots of memory loss
Clinical outcomes and in-hospital mortality rate following heart valve replacements at a tertiary-care hospital
Too sick to socialize: How the brain and immune system promote staying in bed
Seal milk more refined than breast milk
[Press-News.org] When injured muscles mistakenly grow bonesResearchers discover brain chemical that causes strange, serious complication

